Cargando…

Molecular Docking of Cryptoconcatones to α-Tubulin and Related Pironetin Analogues

Cryptoconcatones A-L represent a series of 12 dihydropyrone derivatives isolated from the evergreen tree Cryptocarya concinna Hance, which is well distributed in southeast Asia. The lead compound in the series, cryptoconcatone L, has revealed antiproliferative activity against cultured cancer cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Vergoten, Gérard, Bailly, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860703/
https://www.ncbi.nlm.nih.gov/pubmed/36679009
http://dx.doi.org/10.3390/plants12020296
_version_ 1784874652410052608
author Vergoten, Gérard
Bailly, Christian
author_facet Vergoten, Gérard
Bailly, Christian
author_sort Vergoten, Gérard
collection PubMed
description Cryptoconcatones A-L represent a series of 12 dihydropyrone derivatives isolated from the evergreen tree Cryptocarya concinna Hance, which is well distributed in southeast Asia. The lead compound in the series, cryptoconcatone L, has revealed antiproliferative activity against cultured cancer cells but its mechanism of action remains unknown. Based on a structural analogy with the anticancer natural product pironetin, which is well known for binding covalently to α-tubulin and for functioning as a microtubule polymerization inhibitor, we investigated the interaction of cryptoconcatones with tubulin dimers using molecular docking. The α-tubulin binding capacity of each compound was quantified (through calculation of the empirical energy of interaction ΔE) and structure–binding relationships were delineated. Two compounds were found to interact with α-tubulin much more potently than pironetin: cryptoconcatones F and L. In both cases, the facile formation of a covalent bond with Cys316 was evidenced, as observed with the parent compound pironetin. A few other pironetin analogues were investigated, including spicigerolide, which is an analogue of another known α-tubulin binder. Altogether, this study points to the identification of a series of 5,6-dihydro-α-pyrones as α-tubulin-binding agents. The study contributes to a better understanding of the mechanism of action of cryptoconcatones and should help the design of analogues targeting the pironetin site of α-tubulin.
format Online
Article
Text
id pubmed-9860703
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98607032023-01-22 Molecular Docking of Cryptoconcatones to α-Tubulin and Related Pironetin Analogues Vergoten, Gérard Bailly, Christian Plants (Basel) Article Cryptoconcatones A-L represent a series of 12 dihydropyrone derivatives isolated from the evergreen tree Cryptocarya concinna Hance, which is well distributed in southeast Asia. The lead compound in the series, cryptoconcatone L, has revealed antiproliferative activity against cultured cancer cells but its mechanism of action remains unknown. Based on a structural analogy with the anticancer natural product pironetin, which is well known for binding covalently to α-tubulin and for functioning as a microtubule polymerization inhibitor, we investigated the interaction of cryptoconcatones with tubulin dimers using molecular docking. The α-tubulin binding capacity of each compound was quantified (through calculation of the empirical energy of interaction ΔE) and structure–binding relationships were delineated. Two compounds were found to interact with α-tubulin much more potently than pironetin: cryptoconcatones F and L. In both cases, the facile formation of a covalent bond with Cys316 was evidenced, as observed with the parent compound pironetin. A few other pironetin analogues were investigated, including spicigerolide, which is an analogue of another known α-tubulin binder. Altogether, this study points to the identification of a series of 5,6-dihydro-α-pyrones as α-tubulin-binding agents. The study contributes to a better understanding of the mechanism of action of cryptoconcatones and should help the design of analogues targeting the pironetin site of α-tubulin. MDPI 2023-01-08 /pmc/articles/PMC9860703/ /pubmed/36679009 http://dx.doi.org/10.3390/plants12020296 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Vergoten, Gérard
Bailly, Christian
Molecular Docking of Cryptoconcatones to α-Tubulin and Related Pironetin Analogues
title Molecular Docking of Cryptoconcatones to α-Tubulin and Related Pironetin Analogues
title_full Molecular Docking of Cryptoconcatones to α-Tubulin and Related Pironetin Analogues
title_fullStr Molecular Docking of Cryptoconcatones to α-Tubulin and Related Pironetin Analogues
title_full_unstemmed Molecular Docking of Cryptoconcatones to α-Tubulin and Related Pironetin Analogues
title_short Molecular Docking of Cryptoconcatones to α-Tubulin and Related Pironetin Analogues
title_sort molecular docking of cryptoconcatones to α-tubulin and related pironetin analogues
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860703/
https://www.ncbi.nlm.nih.gov/pubmed/36679009
http://dx.doi.org/10.3390/plants12020296
work_keys_str_mv AT vergotengerard moleculardockingofcryptoconcatonestoatubulinandrelatedpironetinanalogues
AT baillychristian moleculardockingofcryptoconcatonestoatubulinandrelatedpironetinanalogues